Cargando…
Transitioning patients with immune thrombocytopenia to second‐line therapy: Challenges and best practices
In patients with immune thrombocytopenia who do not adequately respond to first‐line therapy, there is no clear consensus on which second‐line therapy to initiate and when. This situation leads to suboptimal approaches, including prolonged exposure to treatments that are not intended for long‐term u...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055642/ https://www.ncbi.nlm.nih.gov/pubmed/29574922 http://dx.doi.org/10.1002/ajh.25092 |